Department of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, 5230 Odense M, Denmark; Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, 20133 Milan, Italy.
Department of Neurobiology Research, Institute of Molecular Medicine, University of Southern Denmark, 5230 Odense M, Denmark.
Brain Behav Immun. 2024 Feb;116:269-285. doi: 10.1016/j.bbi.2023.12.025. Epub 2023 Dec 22.
Microglia, the resident immune cells of the central nervous system (CNS), play a major role in damage progression and tissue remodeling after acute CNS injury, including ischemic stroke (IS) and spinal cord injury (SCI). Understanding the molecular mechanisms regulating microglial responses to injury may thus reveal novel therapeutic targets to promote CNS repair. Here, we investigated the role of microglial tumor necrosis factor receptor 2 (TNFR2), a transmembrane receptor previously associated with pro-survival and neuroprotective responses, in shaping the neuroinflammatory environment after CNS injury. By inducing experimental IS and SCI in Cx3cr1:Tnfrsf1b mice, selectively lacking TNFR2 in microglia, and corresponding Tnfrsf1b littermate controls, we found that ablation of microglial TNFR2 significantly reduces lesion size and pro-inflammatory cytokine levels, and favors infiltration of leukocytes after injury. Interestingly, these effects were paralleled by opposite sex-specific modifications of microglial reactivity, which was found to be limited in female TNFR2-ablated mice compared to controls, whereas it was enhanced in males. In addition, we show that TNFR2 protein levels in the cerebrospinal fluid (CSF) of human subjects affected by IS and SCI, as well as healthy donors, significantly correlate with disease stage and severity, representing a valuable tool to monitor the inflammatory response after acute CNS injury. Hence, these results advance our understanding of the mechanisms regulating microglia reactivity after acute CNS injury, aiding the development of sex- and microglia-specific, personalized neuroregenerative strategies.
小胶质细胞是中枢神经系统(CNS)的固有免疫细胞,在急性 CNS 损伤后的损伤进展和组织重塑中发挥主要作用,包括缺血性中风(IS)和脊髓损伤(SCI)。因此,了解调节小胶质细胞对损伤反应的分子机制可能揭示促进 CNS 修复的新的治疗靶点。在这里,我们研究了小胶质细胞肿瘤坏死因子受体 2(TNFR2)的作用,TNFR2 是一种先前与生存和神经保护反应相关的跨膜受体,在 CNS 损伤后塑造神经炎症环境中发挥作用。通过在 Cx3cr1:Tnfrsf1b 小鼠中诱导实验性 IS 和 SCI,选择性地在小胶质细胞中缺失 TNFR2 及其相应的 Tnfrsf1b 同窝对照,我们发现,小胶质细胞 TNFR2 的缺失显著减少了损伤体积和促炎细胞因子水平,并有利于损伤后的白细胞浸润。有趣的是,这些效应与小胶质细胞反应的相反性别特异性修饰平行,与对照相比,TNFR2 缺失的雌性小鼠中发现小胶质细胞反应受到限制,而雄性小鼠中增强。此外,我们表明,脑脊液(CSF)中 TNFR2 蛋白水平在患有 IS 和 SCI 的人类受试者以及健康供体中,与疾病阶段和严重程度显著相关,代表了监测急性 CNS 损伤后炎症反应的有价值工具。因此,这些结果促进了我们对调节急性 CNS 损伤后小胶质细胞反应的机制的理解,有助于开发针对性别和小胶质细胞的个性化神经再生策略。